Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Non-small Cell Lung Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05713006
What this trial is testing

Alectinib Pharmacokinetic in Patients With NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIIBALK Gene Mutation
Instituto Nacional de Cancerologia de Mexico 45
Early research (Phase 1)Study completedNCT00712504
What this trial is testing

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

Who this might be right for
Advanced Solid TumorsNon Small Cell Lung Cancer
Pfizer 49
Not applicableUnknownNCT03046316
What this trial is testing

Local Therapy in Advanced NSCLC With Non-progressive Disease (PD) After First Line Therapy

Who this might be right for
Lung Neoplasms
Guangdong Association of Clinical Trials 60
Testing effectiveness (Phase 2)Study completedNCT02289833
What this trial is testing

Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 49
Early research (Phase 1)Ended earlyNCT03509584
What this trial is testing

Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients

Who this might be right for
Non-small Cell Lung Cancer
Assistance Publique Hopitaux De Marseille 6
Large-scale testing (Phase 3)Looking for participantsNCT07662395
What this trial is testing

SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Double Blind
Sinocelltech Ltd. 410
Testing effectiveness (Phase 2)UnknownNCT02733107
What this trial is testing

The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Third Military Medical University 25
Testing effectiveness (Phase 2)UnknownNCT03460275
What this trial is testing

Osimertinib as First-line Therapy for Patients With Late-stage Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 100
Large-scale testing (Phase 3)Looking for participantsNCT07155187
What this trial is testing

Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
AbbVie 490
Early research (Phase 1)Active Not RecruitingNCT06544655
What this trial is testing

BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 213
Testing effectiveness (Phase 2)Study completedNCT00252382
What this trial is testing

Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Sunesis Pharmaceuticals 31
Early research (Phase 1)Looking for participantsNCT07046923
What this trial is testing

LY4175408 in Participants With Advanced Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungSmall Cell Lung CarcinomaEndometrial Neoplasms+2 more
Eli Lilly and Company 240
Testing effectiveness (Phase 2)UnknownNCT02974933
What this trial is testing

Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Wuling Ou 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT03896074
What this trial is testing

Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT)

Who this might be right for
Non-small-cell Lung Cancer Patients
Fondazione Ricerca Traslazionale 206
Not applicableLooking for participantsNCT07510724
What this trial is testing

Real-World Data on the Treatment of Lung Cancer Patients With the Immune-Checkpoint Inhibitor Tislelizumab

Who this might be right for
Small Cell Lung Cancer (SCLC)Non-Small Cell Lung Cancer (NSCLC)Lung Cancer (Diagnosis)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 240
Testing effectiveness (Phase 2)UnknownNCT02005120
What this trial is testing

Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Zhejiang University 20
Testing effectiveness (Phase 2)Study completedNCT01362296
What this trial is testing

An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 134
Testing effectiveness (Phase 2)Looking for participantsNCT04787042
What this trial is testing

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Who this might be right for
CancerSolid TumorMelanoma+6 more
Simcha IL-18, Inc. 316
Testing effectiveness (Phase 2)Study completedNCT03958097
What this trial is testing

Natural Killer(NK) Cell Combined With Programmed Death-1(PD-1) Antibody as Second Line Therapy for Advanced Driver Mutation Negative Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
The First Hospital of Jilin University 20
Early research (Phase 1)Study completedNCT01352962
What this trial is testing

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

Who this might be right for
Urethral NeoplasmsNeoplasms, UrethralCancer of the Urethra+1 more
National Cancer Institute (NCI) 18
Next Page